Syngenta Licenses TAL Technology from Two Blades Foundation | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Two Blades Foundation has granted Syngenta access to its genome engineering technology for commercial uses in certain crop plants under an agreement announced late on Tuesday.

The non-exclusive license provides Syngenta access to the Transcription Activator Like (TAL) effector Code, a technology for engineering proteins that bind to specific DNA sequences for precise modulation of genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.